GRAIL stock jumps as Galleri outlook and FDA filing timeline come back into focus
Shares of GRAIL surged 13.2% to $114.41 Thursday afternoon, topping out at an intraday high of $118.50 earlier in the session.
Today’s highest-ranked model selections.